Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer
Clinical trial NCT05564897 · UNKNOWN
Trial details
- NCT number
- NCT05564897
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2024-09-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.